JP2022537178A5 - - Google Patents

Info

Publication number
JP2022537178A5
JP2022537178A5 JP2021574909A JP2021574909A JP2022537178A5 JP 2022537178 A5 JP2022537178 A5 JP 2022537178A5 JP 2021574909 A JP2021574909 A JP 2021574909A JP 2021574909 A JP2021574909 A JP 2021574909A JP 2022537178 A5 JP2022537178 A5 JP 2022537178A5
Authority
JP
Japan
Prior art keywords
prevotella
human
use according
model
copd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021574909A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022537178A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/038084 external-priority patent/WO2020257248A1/en
Publication of JP2022537178A publication Critical patent/JP2022537178A/ja
Publication of JP2022537178A5 publication Critical patent/JP2022537178A5/ja
Pending legal-status Critical Current

Links

JP2021574909A 2019-06-17 2020-06-17 プレボテラ調製物ならびに慢性閉塞性肺疾患（ｃｏｐｄ）および他の肺状態の治療 Pending JP2022537178A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962862186P 2019-06-17 2019-06-17
US62/862,186 2019-06-17
PCT/US2020/038084 WO2020257248A1 (en) 2019-06-17 2020-06-17 Prevotella preparations and treating chronic obstructive pulmonary disease (copd) and other lung conditions

Publications (2)

Publication Number Publication Date
JP2022537178A JP2022537178A (ja) 2022-08-24
JP2022537178A5 true JP2022537178A5 (enExample) 2023-05-09

Family

ID=74037580

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021574909A Pending JP2022537178A (ja) 2019-06-17 2020-06-17 プレボテラ調製物ならびに慢性閉塞性肺疾患（ｃｏｐｄ）および他の肺状態の治療

Country Status (11)

Country Link
US (1) US20220296657A1 (enExample)
EP (1) EP3983067A4 (enExample)
JP (1) JP2022537178A (enExample)
KR (1) KR20220024466A (enExample)
CN (1) CN114340732A (enExample)
AU (1) AU2020295393A1 (enExample)
BR (1) BR112021025416A2 (enExample)
CA (1) CA3143597A1 (enExample)
CO (1) CO2022000029A2 (enExample)
MX (1) MX2021015711A (enExample)
WO (1) WO2020257248A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3037451T3 (en) * 2018-11-30 2025-10-02 Ospedale San Raffaele Srl Prevotella melaninogenica strain for use against cancer or diabetes
US20240148797A1 (en) * 2021-02-26 2024-05-09 Evelo Biosciences, Inc. Compositions and methods for reducing cytokine expression
WO2022187064A1 (en) * 2021-03-01 2022-09-09 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023146843A1 (en) * 2022-01-25 2023-08-03 Evelo Biosciences, Inc. Extracellular vesicle compositions and methods of use
WO2023200837A1 (en) * 2022-04-13 2023-10-19 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2024097250A1 (en) * 2022-10-31 2024-05-10 The Trustees Of Columbia University In The City Of New York Polymeric carrier for probiotics

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965787A (en) 1995-08-31 1999-10-12 Mayo Foundation For Medical Education And Research HLA-DRBI peptides with specific binding affinity for HLA-DQ molecules: prevention and treatment of rheumatoid arthritis
WO2004009776A2 (en) * 2002-07-19 2004-01-29 Abbott Biotechnology Ltd. TREATMENT OF TNFα RELATED DISORDERS
JP4850715B2 (ja) * 2003-12-17 2012-01-11 エヌ．ブイ．・ヌートリシア 乳酸産生菌及び肺機能
US20080241226A1 (en) 2007-03-27 2008-10-02 Abeln Susan L Methods and Kits For Administering Probiotics
WO2011053653A2 (en) * 2009-10-30 2011-05-05 Mayo Foundation For Medical Education And Research Prevotella histicola preparations and the treatment of autoimmune conditions
JP2014196260A (ja) * 2013-03-29 2014-10-16 公立大学法人奈良県立医科大学 慢性閉塞性肺疾患の予防又は治療用組成物
WO2016126831A1 (en) * 2015-02-03 2016-08-11 Mayo Foundation For Medical Education And Research Methods and materials for assessing and treating arthritis
EP3347458A4 (en) * 2015-09-09 2019-08-07 Revivicor Inc. MULTI TRANSGENIC PIG FOR XENOTRANSPLANTATION
JP7055814B2 (ja) * 2017-02-28 2022-04-18 プリシジョンバイオティクス・グループ・リミテッド 呼吸器ウイルス感染症に対する免疫応答を有利に調節することができるビフィドバクテリウム・ロンガム
WO2019004668A1 (ko) * 2017-06-30 2019-01-03 주식회사 엠디헬스케어 프로테우스 속 세균 유래 나노소포 및 이의 용도
EP3679057A1 (en) * 2017-09-08 2020-07-15 Evelo Biosciences, Inc. Extracellular vesicles from prevotella
ES3037451T3 (en) * 2018-11-30 2025-10-02 Ospedale San Raffaele Srl Prevotella melaninogenica strain for use against cancer or diabetes

Similar Documents

Publication Publication Date Title
JP2022537178A5 (enExample)
CN111228275B (zh) 一种化合物在制备治疗病毒性肺炎药物中的应用
Jansen et al. Are inhaled mRNA vaccines safe and effective? A review of preclinical studies
JP2013126989A5 (enExample)
JPH06507404A (ja) 感染性の呼吸性疾患の治療方法
JP2015517489A5 (enExample)
CN103357010A (zh) 疫苗组合物
JP2023520323A5 (enExample)
JP2000505447A (ja) ウリジン三リン酸及び関連化合物で中耳炎を治療する方法
JP2010508365A5 (enExample)
BRPI0906851A2 (pt) uso de um sal do ácido acetilsalicílico para tratamento de infecções virais.
RU2554745C2 (ru) Рекомбинантный человеческий белок сс10 для лечения гриппа
JP2003513935A5 (enExample)
JP5970465B2 (ja) ペプチドおよびウイルス・ノイラミニダーゼ阻害剤を含んでなる組成物
CN106659751A (zh) 口腔可分散膜
JP2024541569A5 (enExample)
JP2022534776A5 (enExample)
JP2019516797A (ja) 鼻詰まりを治療／予防するためのカルボン酸
JP2023536269A5 (enExample)
US20230181697A1 (en) Use of Surfactant Protein D to Treat Viral Infections
JP2023518376A5 (enExample)
TW200816991A (en) Treatment and prevention of intestinal fibrosis
Bergmann et al. Lung mechanics in orally immunized mice after aerolized exposure to influenza virus
JP2023091085A (ja) 粘膜アジュバント
WO2023217189A2 (zh) 一种呼吸道合胞病毒腺病毒载体疫苗及其制备方法和应用